American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. - Wikidata - awgldk - TriplyDB

American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.

American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.

http://www.wikidata.org/entity/Q36984787

about

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies Venous thromboembolism and lung cancer: a review Anticoagulants in cancer Biomolecular markers of cancer-associated thromboembolism Thromboprophylaxis guidelines in cancer with a primary focus on ambulatory patients receiving chemotherapy: a review from the Southern Network on Adverse Reactions (SONAR)Venous thromboembolism in the cancer population: pathology, risk, and prevention Angiogenic inhibitors for older patients with advanced colorectal cancer: does the age hold the stage?Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis Venous and arterial thrombotic risks with thalidomide: evidence and practical guidance What is the Best Treatment for a Cancer Patient with Thrombosis?Risk of venous thromboembolic events associated with VEGFR-TKIs: a systematic review and meta-analysis Real-Time Label-Free Embolus Detection Using In Vivo Photoacoustic Flow Cytometry Venous thromboembolism in malignant gliomas Cancer-associated thrombosis.Saddle pulmonary embolism in a cancer patient with thrombocytopenia: a treatment dilemma.Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera.Low-molecular-weight heparin versus placebo for the prevention of venous thromboembolism in metastatic breast cancer or stage III/IV lung cancer.Treating venous thromboembolism in patients with cancer.The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies.Understanding, recognizing, and managing toxicities of targeted anticancer therapies.Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study.Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort.Primary thromboprophylaxis in the palliative care setting: a qualitative systematic review.Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action.Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts.The role of thromboprophylaxis in cancer patients: emerging data.Deep Vein Thrombosis of the Upper Extremity.Pattern of frequent but nontargeted pharmacologic thromboprophylaxis for hospitalized patients with cancer at academic medical centers: a prospective, cross-sectional, multicenter study.The potential benefits of low-molecular-weight heparins in cancer patients Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline Evidence-based guidance on venous thromboembolism in patients with solid tumours The role of platelets in tumour growth.Heparin based prophylaxis to prevent venous thromboembolic events and death in patients with cancer - a subgroup analysis of CERTIFY.Role of factor xa inhibitors in cancer-associated thrombosis: any new data?Diagnosis and management of people with venous thromboembolism and advanced cancer: how do doctors decide? A qualitative study.Clinical practice guidelines and consensus statements in oncology--an assessment of their methodological quality.

P2860

Q24203644-6515BD58-3D3C-4F57-8FA4-2606AB73986F Q24235587-1E515478-434B-4B98-947D-21977C72FF85 Q26741697-F0A1F2C7-656B-4907-81B7-DAAD25F77555 Q26751511-CB9C9AC6-5BA0-4B03-81CF-A3CCCAC4718D Q26784184-8244EAB3-62CF-4DE8-819B-61192FF92184 Q26825228-5712864B-5915-4AAA-9108-9AA2FC3C1B56 Q26865716-05CD4D36-54F0-434E-8DC9-6708B105117E Q26995284-4F1DEEF8-D3EC-4718-AF2D-48BE70192A9A Q26996508-458E9FAD-2225-4741-99A5-7C601E19B775 Q27002538-D93243E7-713D-49A3-9A34-D5D1AF205DD1 Q27005043-9E2D848E-F2F1-42E8-892F-DBA6A42B92D0 Q27008491-1278EDB2-C17A-4E9B-AFB0-1601459C1A80 Q27009514-FF6E1D58-43EB-408E-8C6D-C18C6A766A12 Q27026453-49013889-E7FA-4AED-B39B-07DE8E8CED3C Q30381707-317DDF74-D89A-46A9-B414-7818F33ED94C Q30436810-6ADB1136-047E-4778-AF55-BDB972F7330C Q33389006-B396520B-C4A9-4EDF-80F9-24A96F2070B1 Q33393653-16C079F9-32AB-4F81-B887-CD58FD6C361A Q33398180-5310D68D-6F2F-46E6-BEF7-BAAD929C8D00 Q33399333-A61F03BB-DDAC-46E5-958B-8BCC31DA8BEF Q33400564-C8443E04-0FEB-45D9-B257-DB5138A39280 Q33402515-F0F3F871-BDFC-44A8-AEFD-517536B2F581 Q33408049-8A93A6E7-CD95-4AAC-8D48-689926E39998 Q33439387-38E106AA-C3EA-42CF-9951-488F251F80FA Q33440816-AB05D073-8AE5-4343-867D-ABE0391DC7C9 Q33548617-E7AAE316-5035-41F6-B483-0E2742AD499D Q33561213-2F6922EC-693D-4F07-ADDF-8165E3CF020B Q33590396-6F6DE320-E603-4A4F-AC12-20C14D3FA5C6 Q33619196-92B861FB-05B1-49EF-8876-792F036EC161 Q33625063-9901DEC9-5D84-4E6A-BAF7-11B6A62A95B1 Q33635174-B5B4C954-66F5-4E69-BF67-A9F60E0900FF Q33691499-6948B3C7-7938-44B7-8262-4120BCF08C8F Q33698360-1CA11217-FAF5-4769-9865-A38006EE59DB Q33763941-703253BB-AE16-4E4A-BE9B-FA58159C12D5 Q33763946-8264C5D9-A4EB-4683-9507-77BAE63AAFDF Q33803558-E69155EF-90BF-4541-825B-2EA69B149713 Q33972130-569F012E-3759-4725-8F90-D311A10E63D5 Q34052232-CA197FA9-478F-4AAF-B6A8-CE199F0CF5F9 Q34346557-56DE1EB9-2C13-4336-88E1-0432887D01D3 Q34362184-FCAD804C-A159-4A85-A421-3F9A1243DA53

P2860

American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.

http://www.wikidata.org/entity/Q36984787

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

American Society of Clinical O ...... tment in patients with cancer.

@en

type

label

American Society of Clinical O ...... tment in patients with cancer.

@en

prefLabel

American Society of Clinical O ...... tment in patients with cancer.

@en

P1433

Q36984787-9392A045-F7E2-4963-88E8-1DAA7F1D6683

P1476

Q36984787-AB08104A-E67A-45E6-BD57-FA9EC2EE9E27

P2093

Q36984787-0215B09A-FA2D-47FB-9A40-767D6B962D96

Q36984787-3AD33AB9-6FC0-493D-974B-2A81871BD7A5

Q36984787-3C33D15E-82C1-4F62-A931-B4154409E39E

Q36984787-41DA3174-354B-4049-ADF3-638644D1A4D3

Q36984787-434CF031-265A-4036-BBF6-CBB98D6809FD

Q36984787-5CFF2509-DA6D-4FEF-B272-78A70F0B4FA9

Q36984787-81366DB3-A0CD-437C-925B-E75EAC2972A1

Q36984787-830CD6B1-C124-46E9-8F34-A7F1813A489B

Q36984787-92CDB707-7838-4E12-BB5A-40239A8E6120

Q36984787-93419849-99DB-4B30-9D24-F9737D4FBC66

P304

Q36984787-BE91C05A-27BC-4EC2-B425-F9F05055104A

P31

Q36984787-5EF99BD3-D7D9-4BD4-9FAD-D908E332CD70

P356

Q36984787-47FD7339-E43F-4946-8E4C-DF5218263E1A

P407

Q36984787-B46EDC6B-8674-4963-9CF6-96660491EA15

P433

Q36984787-257E9919-9081-4C86-BCA8-8771396E0997

P478

Q36984787-B983AE83-B090-4481-9F13-D10462D246D0

P50

Q36984787-1B14F75D-0770-4C78-B257-C4C69527806D

Q36984787-586B0B79-F518-4018-BBD0-8CA750F2D270

Q36984787-F42B5533-70D2-4C82-953C-44E1EF6A4303

P577

Q36984787-7BC3997C-8674-444F-8555-173347EC3FD0

P698

Q36984787-8C17A13A-FC4C-4621-9248-AE66C079034E

P921

Q36984787-A7F5601D-1A7C-4E97-B877-7EEFF3699833

P356

JCO.2007.14.1283

P1433

Journal of Clinical Oncology

P1476

American Society of Clinical O ...... atment in patients with cancer

@en

P2093

Ajay Kakkar

http://www.w3.org/2001/XMLSchema#string

American Society of Clinical Oncology

http://www.w3.org/2001/XMLSchema#string

Charles W Francis

http://www.w3.org/2001/XMLSchema#string

Christopher Flowers

http://www.w3.org/2001/XMLSchema#string

Daniel Clarke-Pearson

http://www.w3.org/2001/XMLSchema#string

David Mendelson

http://www.w3.org/2001/XMLSchema#string

David Trent

http://www.w3.org/2001/XMLSchema#string

Gary H Lyman

http://www.w3.org/2001/XMLSchema#string

Gary Raskob

http://www.w3.org/2001/XMLSchema#string

Howard Liebman

http://www.w3.org/2001/XMLSchema#string

P304

5490-5505

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2007.14.1283

http://www.w3.org/2001/XMLSchema#string

P407

P433

34

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Paul A Thodiyil

P577

2007-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17968019

http://www.w3.org/2001/XMLSchema#string

P921

venous thromboembolism